Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use.

MacAdam H, Zaoutis TE, Gasink LB, Bilker WB, Lautenbach E.

Int J Antimicrob Agents. 2006 Oct;28(4):325-32. Epub 2006 Aug 24. Review.

PMID:
16934439
2.

Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Park SY, Kang CI, Joo EJ, Ha YE, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.

Microb Drug Resist. 2012 Oct;18(5):518-24. doi: 10.1089/mdr.2012.0067. Epub 2012 Jun 28.

PMID:
22742454
3.

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO.

Clin Infect Dis. 2001 Oct 15;33(8):1288-94. Epub 2001 Sep 14.

PMID:
11565067
4.

Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance.

Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H.

Braz J Infect Dis. 2009 Dec;13(6):403-7.

5.

Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.

Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E.

Clin Infect Dis. 2005 May 1;40(9):1317-24. Epub 2005 Mar 30.

PMID:
15825035
6.
7.

Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.

Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.

J Microbiol Immunol Infect. 2012 Jun;45(3):193-9. doi: 10.1016/j.jmii.2011.11.003. Epub 2012 May 12.

8.

Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.

Starlander G, Yin H, Edquist P, Melhus Å.

APMIS. 2014 Jan;122(1):59-67. doi: 10.1111/apm.12102. Epub 2013 Jun 12.

PMID:
23755901
9.

Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.

Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.

J Antimicrob Chemother. 2007 Sep;60(3):629-37. Epub 2007 Jun 27.

PMID:
17599919
12.

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.

Clin Infect Dis. 2001 Apr 15;32(8):1162-71. Epub 2001 Mar 26.

PMID:
11283805
13.
14.

Antibiogram and plasmid profiling of carbapenemase and extended spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Abeokuta, South western, Nigeria.

Motayo BO, Akinduti PA, Adeyakinu FA, Okerentugba PO, Nwanze JC, Onoh CC, Innocent-Adiele HC, Okonko IO.

Afr Health Sci. 2013 Dec;13(4):1091-7. doi: 10.4314/ahs.v13i4.33.

15.

Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia.

Matsumura Y, Yamamoto M, Matsushima A, Nagao M, Ito Y, Takakura S, Ichiyama S.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1931-9. doi: 10.1007/s10096-011-1523-4. Epub 2011 Dec 31.

16.

Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland.

Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, Ledergerber B, Weber R.

Infection. 2010 Feb;38(1):33-40. doi: 10.1007/s15010-009-9207-z. Epub 2010 Jan 27.

PMID:
20108162
18.

Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.

Chopra T, Marchaim D, Johnson PC, Chalana IK, Tamam Z, Mohammed M, Alkatib S, Tansek R, Chaudhry K, Zhao JJ, Pogue JM, Kaye KS.

Am J Infect Control. 2015 Jul 1;43(7):719-23. doi: 10.1016/j.ajic.2015.02.030. Epub 2015 Apr 29.

PMID:
25934068
19.
20.

Supplemental Content

Support Center